Toward a core nutraceutical program for cancer management. Export

@article{citeulike:737838, abstract = {As previously suggested, it may be feasible to impede tumorevoked angiogenesis with a nutraceutical program composed of glycine, fish oil, epigallocatechin-3-gallate, selenium, and silymarin, complemented by a low-fat vegan diet, exercise training, and, if feasible, a salicylate and the drug tetrathiomolybdate. It is now proposed that the scope of this program be expanded to address additional common needs of cancer patients: blocking the process of metastasis; boosting the cytotoxic capacity of innate immune defenses (natural killer [NK] cells); preventing cachexia, thromboembolism, and tumor-induced osteolysis; and maintaining optimal micronutrient status. Modified citrus pectin, a galectin-3 antagonist, has impressive antimetastatic potential. Mushroombeta-glucans and probiotic lactobacilli can amplify NK activity via stimulatory effects on macrophages. Selenium, beta-carotene, and glutamine can also increase the number and/or cytotoxic activity of NK cells. Cachectic loss of muscle mass can be opposed by fish oil, glutamine, and beta-hydroxy-beta-methylbutyrate. Fish oil, policosanol, and vitamin D may have potential for control of osteolysis. High-dose aspirin or salicylates, by preventing NF-B activation, can be expected to aid prevention of metastasis and cachexia while down-regulating osteolysis, but their impacts on innate immune defenses will not be entirely favorable. A nutritional insurance formula crafted for the special needs of cancer patients can be included in this regimen. To minimize patient inconvenience, this complex core nutraceutical program could be configured as an oil product, a powder, and a capsule product, with the nutritional insurance formula provided in tablets. It would be of interest to test this program in nude mouse xenograft models.}, address = {Block Center for Integrative Cancer Care, Evanston, IL 60201, USA. mccarty@pantox.com}, author = {McCarty, M. F. and Block, K. I.}, citeulike-article-id = {737838}, citeulike-linkout-0 = {http://dx.doi.org/10.1177/1534735406288443}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/16685077}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=16685077}, doi = {10.1177/1534735406288443}, issn = {1534-7354}, journal = {Integr Cancer Ther}, keywords = {aging, anti, anti-aging, cancer, molecular-biology, nutraceuticals}, month = {June}, number = {2}, pages = {150--171}, posted-at = {2009-07-09 07:20:20}, priority = {2}, title = {Toward a core nutraceutical program for cancer management.}, url = {http://dx.doi.org/10.1177/1534735406288443}, volume = {5}, year = {2006} }

TY - JOUR ID - citeulike:737838 L3 - citeulike-article-id:737838 N2 - As previously suggested, it may be feasible to impede tumorevoked angiogenesis with a nutraceutical program composed of glycine, fish oil, epigallocatechin-3-gallate, selenium, and silymarin, complemented by a low-fat vegan diet, exercise training, and, if feasible, a salicylate and the drug tetrathiomolybdate. It is now proposed that the scope of this program be expanded to address additional common needs of cancer patients: blocking the process of metastasis; boosting the cytotoxic capacity of innate immune defenses (natural killer [NK] cells); preventing cachexia, thromboembolism, and tumor-induced osteolysis; and maintaining optimal micronutrient status. Modified citrus pectin, a galectin-3 antagonist, has impressive antimetastatic potential. Mushroombeta-glucans and probiotic lactobacilli can amplify NK activity via stimulatory effects on macrophages. Selenium, beta-carotene, and glutamine can also increase the number and/or cytotoxic activity of NK cells. Cachectic loss of muscle mass can be opposed by fish oil, glutamine, and beta-hydroxy-beta-methylbutyrate. Fish oil, policosanol, and vitamin D may have potential for control of osteolysis. High-dose aspirin or salicylates, by preventing NF-B activation, can be expected to aid prevention of metastasis and cachexia while down-regulating osteolysis, but their impacts on innate immune defenses will not be entirely favorable. A nutritional insurance formula crafted for the special needs of cancer patients can be included in this regimen. To minimize patient inconvenience, this complex core nutraceutical program could be configured as an oil product, a powder, and a capsule product, with the nutritional insurance formula provided in tablets. It would be of interest to test this program in nude mouse xenograft models. IS - 2 JF - Integr Cancer Ther SN - 1534-7354 AD - Block Center for Integrative Cancer Care, Evanston, IL 60201, USA. mccarty@pantox.com EP - 171 TI - Toward a core nutraceutical program for cancer management. VL - 5 SP - 150 KW - aging KW - anti KW - anti-aging KW - cancer KW - molecular-biology KW - nutraceuticals AU - McCarty, MF AU - Block, KI PY - 2006/06// UR - http://dx.doi.org/10.1177/1534735406288443 ER -